AUNPHARMA LIMITEDActive

Company number 07305793Private limited companyIncorporated 2010

Key figures

£301,242+4.1%
Net assets 2024/25
+16.3%
Average annual growth 2019/20–2024/25
0100 k200 k300 k400 k2019/202020/212021/222022/232023/242024/25

AUNPHARMA LIMITED does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0500 k1 m1.5 m2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Profit for the year————11,965
Cash at bank and in hand149,130147,52461,89652,81737,812
Total assets853,148836,4291,216,6011,099,0581,093,776
Total liabilities627,268568,283953,894807,204784,858
Net assets / total equity225,880264,172258,604289,277301,242
Average number of employees12129170

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: AUNPHARMA LIMITED

Company

AUNPHARMA LIMITED is a private limited company registered with Companies House under company number 07305793. It was incorporated on 6 Jul 2010. Its status is active. The registered office is in Portsmouth (PO1). Its nature of business (SIC 2007) is dispensing chemist in specialised stores (47730).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Mar 2025); the company files small company accounts. Profit for the year was £11,965. Net assets were £301,242, up 4.1% on the previous year. Cash at bank and in hand was £37,812. Total assets were £1,093,776 and total liabilities £784,858. The company had an average of 0 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

One person with significant control is registered. 4 of 7 registered charges are outstanding.

Filing deadlines

The next accounts are due by 29 Dec 2026. The next confirmation statement is due by 31 May 2027.